Who owns RLMD?
Institutional ownership of Relmada Therapeutics Inc. from Form 13F, Q2 2026
126 institutional managers reported holding Relmada Therapeutics Inc. (RLMD) in Form 13F filings for Q2 2026, with 100,232,659 shares worth $694M. The largest reported holder was Jupiter Topco LLC. Managers that filed both quarters added a net 15,871,549 shares (+21.7%). 46 opened new positions and 23 sold out.
- Funds holding
- 126
- Value held
- $694M
- New / sold out
- 46 / 23
- Net shares, same filers
- +21.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of RLMD
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Jupiter Topco LLC | $77.3M | 11.1% | 11,164,803 | First report |
| BlackRock, Inc. | $51.4M | 7.4% | 7,426,780 | Added |
| Squadron Capital Management LLC | $50.9M | 7.3% | 7,350,000 | Trimmed |
| Venrock Adviser, LLC | $47.4M | 6.8% | 6,844,305 | Added |
| Spruce Street Capital LP | $44.2M | 6.4% | 6,391,328 | Added |
| Adage Capital Partners GP, L.l.c. | $33.0M | 4.8% | 4,763,158 | Unchanged |
| Vanguard Capital Management LLC | $30.9M | 4.4% | 4,460,210 | Added |
| Jones Hill Capital LP | $25.3M | 3.6% | 3,655,075 | Added |
| Orbimed Advisors LLC | $25.1M | 3.6% | 3,631,195 | Trimmed |
| State Street Corp | $17.4M | 2.5% | 2,517,550 | Added |
| Geode Capital Management, LLC | $17.3M | 2.5% | 2,492,573 | Added |
| Millennium Management LLC | $16.3M | 2.4% | 2,361,827 | Trimmed |
| Marshall Wace, LLP | $15.5M | 2.2% | 2,246,839 | Trimmed |
| Ikarian Capital, LLC | $14.9M | 2.1% | 2,148,359 | Trimmed |
| Driehaus Capital Management LLC | $14.8M | 2.1% | 2,132,053 | Unchanged |
| Ameriprise Financial Inc | $13.4M | 1.9% | 1,937,972 | Added |
| Eventide Asset Management, LLC | $12.9M | 1.9% | 1,858,416 | Added |
| Balyasny Asset Management L.P. | $10.5M | 1.5% | 1,520,688 | Added |
| Stempoint Capital LP | $10.1M | 1.5% | 1,460,093 | Added |
| Commodore Capital LP | $9.9M | 1.4% | 1,425,000 | Added |
| Polar Capital Holdings Plc | $9.3M | 1.3% | 1,340,428 | Trimmed |
| Citadel Advisors LLC | $7.3M | 1.1% | 1,061,665 | New |
| Sio Capital Management, LLC | $6.9M | 1.0% | 1,003,562 | Added |
| Opaleye Management Inc. | $6.5M | 0.9% | 935,000 | Unchanged |
| Vanguard Portfolio Management LLC | $6.2M | 0.9% | 898,198 | New |
Share of 13F holdings is each fund's shares as a share of the 100,232,659 RLMD shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$42.5M
- Jones Hill Capital LP Added+$22.9M
- State Street Corp Added+$15.0M
- Venrock Adviser, LLC Added+$13.8M
- Geode Capital Management, LLC Added+$11.4M
- Ameriprise Financial Inc Added+$9.7M
- Vanguard Capital Management LLC Added+$9.6M
- Balyasny Asset Management L.P. Added+$8.8M
- Citadel Advisors LLC New+$7.3M
- Eventide Asset Management, LLC Added+$7.0M
Biggest sellers in Q2 2026
- Ra Capital Management, L.p. Sold out-$20.5M
- Marshall Wace, LLP Trimmed-$15.5M
- Millennium Management LLC Trimmed-$10.7M
- Squadron Capital Management LLC Trimmed-$7.8M
- Orbimed Advisors LLC Trimmed-$7.5M
- Susquehanna International Group, LLP Trimmed-$6.8M
- Corient Private Wealth LP Sold out-$5.0M
- Ikarian Capital, LLC Trimmed-$3.7M
- Point72 Asset Management, L.P. Sold out-$3.5M
- Jane Street Group, LLC Sold out-$1.5M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $208M and sold $98.1M; 36 added and 22 trimmed.
Schedule 13D and 13G filings on RLMD
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-07-29BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-06-22MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by Relmada Therapeutics Inc.Schedule 13G
- 2026-02-12Adage Capital Management, L.P. SCHEDULE 13G filed by Relmada Therapeutics Inc.Schedule 13G
- 2026-02-06JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Relmada Therapeutics Inc.Schedule 13G
Questions about RLMD ownership
- Who owns RLMD stock?
- 126 institutional investment managers reported RLMD positions in their Form 13F filings for Q2 2026, holding 100,232,659 shares worth $694M in total. Jupiter Topco LLC reported the largest position.
- Are funds buying or selling RLMD?
- In Q2 2026, 46 managers opened new RLMD positions, 36 added, 22 trimmed and 23 sold out. Managers that filed in both quarters added a net 15,871,549 shares.
- How current is this RLMD institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to RLMD by CUSIP. Options are left out. RLMD news and filings · RLMD insider trades · Top funds